Hematologic Malignancies Exhibit Selective Vulnerability To Inhibition Of De Novo Pyrimidine Biosynthesis By Ag-636, A Novel Inhibitor Of Dihydroorotate Dehydrogenase In Phase 1 Clinical Trials
BLOOD(2019)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要